Suspension Formulation Services

Suspension Formulation Services

Developing a stable suspension is one of the most complex challenges in pharmaceutical and chemical formulation. Whether dealing with poorly soluble active pharmaceutical ingredients (APIs) or specialized agrochemicals, achieving physical stability—preventing caking, sedimentation, and Ostwald ripening—requires deep expertise in colloid science and rheology. BOC Sciences provides end-to-end suspension formulation services, ranging from initial particle engineering to final vehicle optimization. Our goal is to transform challenging molecules into robust, homogenous, and user-friendly liquid dosage forms through a data-driven approach that balances thermodynamic stability with kinetic performance.

Suspension Formulation Service Categories

Pre-formulation & R&D

  • API Characterization: Assessing physicochemical properties, crystal forms, and solubility to mitigate design risks.
  • Excipient Optimization: Screening wetting and suspending agents to ensure physical stability and scalability.
  • Stability Studies: Identifying degradation pathways to guide optimal formulation structure and storage.
  • Preclinical Support: Rapid development of toxicology batches and small-scale trial formulations.

Process & Tech Development

  • Multi-Route Systems: Developing oral, injectable, and ophthalmic suspensions with optimized uniformity.
  • Particle Engineering: Using wet milling and homogenization for precise size control and better dissolution.
  • Functional Platforms: Implementing spray drying and coating for taste masking and controlled release.
  • Advanced Modalities: Supporting high-barrier technologies like nanocrystals and dry suspensions.

Analytical & Quality Control

  • CQA Assessment: Monitoring particle size, Zeta potential, and rheology for batch consistency.
  • In Vitro Evaluation: Building discriminative dissolution models to enhance product performance data.
  • Stability Testing: Executing accelerated and freeze-thaw cycles across various storage conditions.
  • Container Compatibility: Evaluating interaction risks between formulations and packaging materials.

Commercial Manufacturing

  • Development Supply: Flexible batch production to meet multi-stage sample and process requirements.
  • Aseptic Filling: Sterile solutions for vials, pre-filled syringes, and ampoules.
  • Scale-up & Transfer: Standardized tech transfer for smooth transition from R&D to mass production.
  • Market Supply: Robust quality management to ensure long-term, stable commercial availability.
Struggling with Suspension Stability and Uniformity?

BOC Sciences offers expert suspension formulation services, ensuring optimal particle size distribution and long-term physical stability for your complex drug products.

Request a Quote

Capabilities & Technological Platforms

BOC Sciences utilizes advanced analytical tools and processing equipment to address the specific hurdles of liquid-dispersed systems, ensuring high precision in particle size and rheological behavior.

Particle Engineering Tools

  • Size Reduction: Nano-milling (Wet), Micronization, and Ultrasonic Homogenization.
  • Crystallization: Controlled precipitation and antisolvent crystallization techniques.
  • Coating: Microencapsulation of suspended particles for taste masking or controlled release.
  • Drying: Spray drying and lyophilization for reconstitutable "Dry Suspension" powders.

Stability Assessment

  • Optical Profiling: Multi-light scattering analysis (Turbiscan) for early detection of instability.
  • Rheological Mapping: Flow curves, yield stress measurement, and viscoelastic profiling.
  • Microscopy: SEM, TEM, and polarized light microscopy for crystal growth monitoring.
  • Sedimentation Volume: Quantitative tracking of phase separation over time (F-value).

Analytical Instrumentation

  • Particle Sizing: Laser Diffraction (D10/D50/D90) and Dynamic Light Scattering (DLS).
  • Solid State: XRD and DSC to monitor polymorphic changes during suspension storage.
  • HPLC/UPLC: Chemical stability and assay testing of active ingredients in complex matrices.
  • Dissolution: Specialized apparatus for drug release profiling from suspension formulations.

Advanced Modeling

  • DLVO Theory: Mathematical modeling of particle-particle interaction energies.
  • Predictive Shelf-life: Accelerated stress testing (freeze-thaw, thermal cycling).
  • Scale-up Simulation: Computational fluid dynamics (CFD) for mixing and filling processes.
  • Design of Experiments (DoE): Systematic screening of excipient concentrations for optimal stability.

Specialized Suspension Modalities

We customize our suspension platforms to meet the specific requirements of different delivery routes and industrial applications.

Oral Suspensions

  • Pediatric/Geriatric formulations
  • Taste-masked API suspensions
  • High-load drug dispersions
  • Reconstitutable dry syrups
  • Nanosuspensions for bioavailability
  • Controlled-release oral liquids

Injectable & Ophthalmic

  • Long-acting injectables (LAI)
  • Sterile ophthalmic suspensions
  • Subcutaneous depot formulations
  • Intramuscular suspensions
  • Lipid-based dispersions
  • Viscosity-optimized eye drops

Topical & Industrial

  • Dermatological lotions/creams
  • Sunscreen mineral dispersions
  • Agrochemical flowables (SC)
  • Cosmetic pigment suspensions
  • Polymer-stabilized colloids
  • Agricultural seed coatings

Suspension Development Project Workflow

Technical Consultation

1Consultation & Feasibility

Review of API properties, target dosage, and specific stability challenges (e.g., rapid sedimentation or poor wetting).

Prototyping

2Formulation Design

Screening of surfactants and polymers to create a stable flocculated or deflocculated system tailored to the application.

Physical Testing

3Characterization & Stress Testing

Executing rigorous testing including particle size distribution, rheology, and thermal cycling to ensure long-term robustness.

Final Reporting

4Optimization & Technology Transfer

Delivery of the final formulation recipe, processing parameters, and comprehensive stability data reports.

Targeted Solutions for Suspension Challenges

01

Overcoming Poor Bioavailability

For BC Class II/IV drugs, we utilize nanosuspension technology to increase the effective surface area of the active ingredient. By reducing particles to the sub-micron range through high-energy milling, we significantly enhance the dissolution rate and absorption kinetics compared to traditional coarse formulations, ensuring that even the most hydrophobic molecules achieve their intended functional performance.

02

Mitigating Crystal Growth (Ostwald Ripening)

Small particles naturally tend to dissolve and redeposit onto larger ones over time, leading to significant stability failure and shelf-life reduction. We employ specialized crystal growth inhibitors and tailored surfactants that specifically adsorb to the crystal surface, effectively lowering interfacial tension and maintaining the desired particle size distribution across varying storage temperatures and durations.

03

Optimizing Rheology & Pourability

A successful suspension must be viscous enough to prevent rapid sedimentation during long-term storage but fluid enough to pour or pump easily during use. We design sophisticated thixotropic systems that exhibit specialized shear-thinning behavior, which allows the formulation to liquefy instantly when shaken or agitated and return to a protective gel-like state when at rest to maintain homogeneity.

04

Preventing Irreversible Caking and Aggregation

The formation of a hard, inseparable mass at the bottom of a container is a primary failure mode for liquid-dispersed systems. Our laboratory addresses this by engineering controlled flocculation systems using precise electrolyte balances and polymeric bridging agents. This creates a loosely associated network of particles that may settle over time but can be instantly and completely re-dispersed with minimal mechanical effort or gentle agitation.

Master the Science of Stable Suspensions

From micron-sized dispersions to complex nano-colloids, BOC Sciences provides the expertise and instrumentation needed to solve your most difficult stability hurdles. Contact us today for a technical assessment of your formulation needs.

Request a Quote

Why Choose BOC Sciences for Suspension Development?

Expertise in Colloid Science

Our formulators possess advanced backgrounds in surface chemistry, enabling them to tackle issues like zeta potential collapse and irreversible aggregation.

Advanced Rheology Laboratory

We use sophisticated rheometers to map the yield stress and flow behavior of every formulation, ensuring consistency across different batches.

High-Throughput Excipient Screening

Our platform allows for the rapid testing of dozens of stabilizer combinations, significantly reducing the timeline for prototype development.

Customized Scale-up Support

We provide detailed processing instructions, including impeller speeds and homogenization pressures, to facilitate a smooth transition to production.

Applications Across Diverse Industries

Pharmaceuticals

  • Antibiotic oral liquids
  • Antacid suspensions
  • Corticosteroid injections
  • Nasal spray formulations

Personal Care

  • Mineral-based sunblocks
  • Exfoliating body washes
  • Pigmented foundation liquids
  • Anti-dandruff shampoos

Agrochemicals

  • Suspension concentrates (SC)
  • Seed treatment flowables
  • Fertilizer dispersions
  • Herbicidal liquid blends

Case Studies: Solving Complex Dispersions

Client Requirement: The client sought to develop a user-friendly, multi-dose oral antibiotic suspension that maintains strict dose uniformity throughout its shelf life without requiring heavy industrial agitation before administration.

Challenge: An oral antibiotic suspension exhibited dense "caking" at the bottom of the bottle after 2 weeks of storage, making it impossible to re-disperse for accurate dosing.

Solution: Our team performed a comprehensive rheological assessment and identified that the system was "deflocculated," where particles settled slowly but eventually packed into a hard, inseparable mass. To rectify this, we engineered a structured vehicle using a synergistic combination of Xanthan Gum for viscosity and a controlled flocculating agent, monobasic potassium phosphate. This specific electrolyte balance reduced the zeta potential to a level that favored the formation of "loose flocs." These flocs create a porous, three-dimensional network that settles more rapidly but remains highly susceptible to shear, allowing for near-instantaneous redispersal.

Outcome: The reformulated product showed a sedimentation volume (F) of 0.85 and was easily re-suspended with three gentle inversions, maintaining dose uniformity.

Client Requirement: A pharmaceutical partner required a specialized formulation strategy to rescue a poorly soluble oncology drug candidate that had previously failed to meet therapeutic plasma levels in early-stage trials.

Challenge: A BCS Class IV oncology candidate showed negligible absorption in animal models due to its large crystalline particle size (>50 microns).

Solution: To maximize the effective surface area and dissolution rate, we utilized high-energy wet bead milling with a planetary mill to engineer a stable nanosuspension. Our formulation scientists screened an extensive library of stabilizers, including various Poloxamers and PVP grades, to identify the optimal steric and electrostatic barrier. By precisely controlling the milling duration and cooling parameters, we prevented the high-energy nanoparticles from aggregating or undergoing Ostwald ripening. This process successfully transitioned the API from a coarse dispersion into a sophisticated, sub-micron colloidal system with enhanced kinetic performance.

Outcome: The particle size was reduced to a stable D50 of 220nm. Subsequent studies showed a 400% increase in Cmax, allowing the project to proceed to efficacy evaluation.

Client Requirement: An agrochemical manufacturer needed a high-concentration flowable concentrate that could withstand extreme environmental conditions during global shipping and seasonal storage.

Challenge: A high-load (500g/L) agrochemical suspension concentrate suffered from severe syneresis (liquid separation) and particle growth when exposed to thermal cycling (-10°C to 40°C).

Solution: Through advanced Turbiscan optical profiling and multi-light scattering analysis, we pinpointed the exact onset of physical instability to a specific surfactant-to-solids ratio. We implemented a robust dual-stabilizer system that utilized a high-molecular-weight polymeric dispersant to provide long-range steric repulsion. Additionally, we incorporated a specialized anti-freeze agent to maintain osmotic balance and prevent crystal nucleation during the drastic temperature fluctuations of thermal cycling. This comprehensive approach ensured that the high-load formulation remained homogenous and free of significant phase separation despite the high solids content.

Outcome: The formulation passed 12 weeks of accelerated aging and thermal cycling without significant crystal growth or phase separation.

Frequently Asked Questions

Frequently Asked Questions

Still have questions?

Contact Us

Client Reviews: Suspension Expertise

Expert Services Supporting Formulation Development

Have a Question or Issue?

If you have any questions or encounter issues on this page, please don't hesitate to reach out. Our support team is ready to assist you.

Online Inquiry
Verification code